Neurodegenerative Disorders
Neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and ALS affect millions globally, often with devastating personal and societal consequences. This track examines the cellular and molecular mechanisms underlying these conditions, including protein aggregation, mitochondrial dysfunction, oxidative stress, and synaptic failure. Discussions will also focus on genetic and environmental risk factors, early diagnostic biomarkers, and emerging therapeutic interventions. Presentations will explore the latest clinical trials, disease-modifying drugs, and non-pharmacological strategies aimed at improving patient outcomes and quality of life. This track is vital for developing approaches to slow, halt, or reverse neurodegeneration.